Roles of leukocyte/endothelial cell adhesion molecules in the pathogenesis of vasculitis

American Journal of Medicine

Volumn 106, Issue 6, 1999, Pages 677-687

  Kevil, Christopher G ^a   Bullard, Daniel C ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN SPECIFICITY; ARTERY ENDOTHELIUM; ARTICLE; AUTOIMMUNITY; CELL ADHESION; CELL DAMAGE; CELL INTERACTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; LYMPHOCYTE ACTIVATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULITIS;

ANIMALS; CELL ADHESION MOLECULES; E-SELECTIN; ENDOTHELIUM, VASCULAR; HUMANS; LEUKOCYTES; VASCULITIS;

EID: 0033003421     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00132-1     Document Type: Article

References (92)

1. Harlan J.M., Liu D.Y. Adhesion Its Role in Inflammatory Disease . 1992;WH Freeman and Company, New York.
2. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration the multistep paradigm . Cell. 76:1994;301-314.
3. Kansas G.S. Selectins and their ligands current concepts and controversies . Blood. 88:1996;111.
4. Larson R.S., Springer T.A. Structure and function of leukocyte integrins. Immunol Rev. 114:1990;181-217.
5. Vieren M.V.D., Trong H.L., Wood C.L., et al. A novel leukointegrin, αdB2, binds preferentially to ICAM-3. Immunity. 3:1995;683-690.
6. Danilenko D.M., Rossitto P.V., Vieren MV-d, et al. A novel canine leukointegrin, alpha(d)beta(2), is expressed by specific macrophage subpopulations in tissue and a minor CD8(+) lymphocyte subpupulation in peripheral blood. J Immunol. 155:1995;34-44.
7. Anderson D.C., Schmalstein F.C., Finegold M.J., et al. The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency their quantitative definition and relation to leukocyte dysfunction and clinical feature . J Infect Dis. 152:1985;668-689.
8. Anderson D.C., Springer T.A. Leukocyte adhesion deficiency an inherited defect in the Mac-1, LFA-1 and p150,95 glycoproteins . Ann Rev Med. 38:1987;175-194.
9. Shuster D.E., Kehrli M.E., Ackerman M.R., Gilbert R.O. Identification and prevalence of a genetic defect that causes leukocyte adhesion deficiency in Holstein cattle. Proc Natl Acad Sci USA. 89:1992;9225-9229.
10. Bevilacqua M.P., Nelson R.M., Mannori G., Cecconi O. Endothelial-leukocyte adhesion molecules in human diseases. Ann Rev Med. 45:1994;361-378.
11. McMurray R.W. Adhesion molecules in autoimmune disease. Sem Arthr Rheum. 25:1996;215-233.
12. Mojcik C.F., Shevach E.M. Adhesion molecules a rheumatologic perspective . Arthr Rheum. 40:1997;991-1004.
13. Ledford D.K. Immunologic aspects of vasculitis and cardiovascular disease. JAMA. 278:1997;1962-1971.
14. Cupps TR. Vasculitis: epidemiology, pathology, and pathogenesis, 11th ed. In: Wortmann R, Klippel JH, eds. Primer on the Rheumatic Diseases: An Official Publication of the Arthritis Foundation 11th ed. Kansas City: Andrew and McMeel, 1998.
15. Hoffman G.S., Specks U. Antineutrophil cytoplasmic antibodies. Arthr Rheum. 41:1998;1521-1537.
16. Locke I.C., Cambridge G. Autoantibodies to neutrophil granule proteins pathogenic potential in vasculitis? Br J Biomed Sci. 53:1996;302-316.
17. Keogan M.T., Esnault V.L.M., Green A.J., Lockwood C.M., Brown D.L. Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies. Clin Exp Immunol. 90:1992;228-234.
18. Del Papa N., Guidali L., Sironi M., et al. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthr Rheum. 39:1996;758-766.
19. Cid M.C. New developments in the pathogenesis of systemic vasculitis. Curr Op Rheum. 8:1996;1-11.
20. Riecken B., Gutfleisch J., Schlesier M., Peter H.H. Impaired granulocyte oxidative burst and decreased expression of leukocyte adhesion molecule-1 (LAM-1) in patients with Wegener's granulomatosis. Clin Exp Immunol. 96:1994;43-47.
21. Haller H., Eichhorn J., Peiper K., Gobel U., Luft F.C. Circulating leukocyte integrin expression in Wegener's granulomatosis. J Am Soc Nephr. 7:1967;40-48.
22. Gutfleisch J., Baumert E., Wolff-Vorbeck G., Schlesier M., Strutz H.J., Peter H.H. Increased expression of CD25 and adhesion molecules on peripheral blood lymphocytes of patients with Wegener's granulomatosis (WG) and ANCA positive vasculitides. Adv Exp Med Biol. 336:1993;397-404.
23. Rastaldi M.P., Ferrario F., Tunesi S., Yang L., D'Amico G. Intraglomerular and interstitial leukocyte infiltration, adhesion molecules, and interleukin-1a expression in 15 cases of antineutrophil cytoplasmic autoantibody-associated renal vasculitis. Am J Kid Dis. 27:1995;48-57.
24. Pall A.A., Howie A.J., Adu D., et al. Glomerular vascular cell adhesion molecule-1 expression in renal vasculitis. J Clin Pathol. 49:1996;238-242.
25. Jennette J.C., Falk R.J., Andrassy K., et al. Nomenclature of systemic vasculitides. Arthr Rheum. 37:1994;187-192.
26. Schoen F. Blood vessels. Cotran R.S., Kumar V., Robbins S.L. Pathologic Basis of Disease. 5th ed. 1994;WB Saunders, Philadelphia.
27. Coll-Vinent B., Cebrian M., Cid M.C., et al. Dynamic patterns of endothelial cell adhesion molecule expression in muscle and perineural vessels from patients with classic polyarteritis nodosa. Arthr Rheum. 41:1998;435-444.
28. Bradley J.R., Lockwood C.W., Thiru S. Endothelial cell activation in patients with systemic vasculitis. QJM. 87:1994;741-745.
29. Sneller M.C., Fauci A.S. Pathogenesis of vasculitis syndromes. Med Clin N Am. 81:1997;221-242.
30. Schaufelberger C., Stemme S., Andersson R., Hansson G.K. T lymphocytes in giant cell arteritic lesions are polyclonal cells expression alpha beta type antigen receptors and VLA-1 integrin receptors. Clin Exp Immunol. 91:1993;421-428.
31. Wawryk S.O., Ayberk H., Boyd A.W., Rode J. Analysis of adhesion molecules in the immunopathogenesis of giant cell arteritis. J Clin Path. 44:1991;497-501.
32. Kotzin B.L. Systemic lupus erythematosus. Cell. 85:1996;303-306.
33. Takeuchi T., Amano K., Sekine H., Koide J., Abe T. Upregulated expression and function of the integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis. J Clin Invest. 92:1993;3008-3016.
34. Belmont H.M., Buyon J., Giorno R., Abramson S. Upregulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus the Schwartzman phenomenon revisited . Arthr Rheum. 37:1994;376-383.
35. Burrows N.P., Molina F.A., Terenghi G., et al. Comparison of cell adhesion molecule expression in cutaneous leucocytoclastic and lymphocytic vasculitis. Am J Kidney Dis. 27:1994;48-57.
36. Sais G., Vidaller A., Jucgla A., Condom E., Peyri J. Adhesion molecule expression and endothelial cell activation in cutaneous leukocytoclastic vasculitis. An immunohistologic and clinical study in 42 patients. Arch Derm. 133:1997;443-450.
37. Panegyres P.K., Faull R.J., Russ G.R., Appleton S.L., Wangel A.G., Blumbergs P.C. Endothelial cell activation in vasculitis of peripheral nerve and skeletal muscle. J Neurol Neurosurg Psych. 55:1992;4-7.
38. Flipo R.M., Cardon T., Copin M.C., Vandecandelaere M., Duquesnoy B., Janin A. ICAM-1, E-selectin, and TNFα expression in labial salivary glands of patients with rheumatoid vasculitis. Ann Rheum Dis. 56:1997;41-44.
39. Tervaert J.W.C., Kallenberg C.G.M. Cell adhesion molecules in vasculitis. Curr Op Rheum. 9:1997;16-25.
40. John S., Neumayer H.H., Weber M. Serum circulating ICAM-1 levels are not useful to indicate active vasculitis or early renal allograft rejection. Clin Nephr. 42:1994;369-375.
41. Mrowka C., Sieberth H.G. Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis marked differences between Wegener's granulomatosis and systemic lupus erythematosus . Clin Invest. 72:1994;762-768.
42. Carson C.W., Beall L.D., Hunder G.G., Johnson C.M., Newman W. Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus. J Rheum. 20:1993;809-814.
43. Pall A.A., Adu D., Drayson M., Taylor C.M., Richards N.T., Michael J. Circulating soluble adhesion molecules in systemic vasculitis. Nephr Dial Transp. 9:1994;770-774.
44. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. J Clin Invest. 52:1973;2745-2756.
45. Granger D.N., Kurose I., Kvietys P.R. Modulation of leukocyte adherence and emigration during ischemia and reperfusion. Granger D.N., Schmid-Schoenbein G.W. Physiology and Pathophysiology of Leukocyte Adhesion. 1995;Oxford, New York.
46. Shappel S.B., Toman C., Anderson D.C., Taylor A.A., Entman M.L., Smith C.W. Mac-1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils. J Immunol. 144:1990;2702-2711.
47. Westlin W.F., Gimbrone M.A.J. Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation. Am J Pathol. 142:1993;117-128.
48. Bradley J.R., Johnson D.R., Pober J.S. Endothelial activation by hydrogen peroxide. Selective increases of intercellular adhesion molecule-1 and major histocompatibility complex class I. Am J Pathol. 142:1993;1598-1609.
49. Bratt J., Palmblad J. Cytokine-induced neutrophil-mediated injury of human endothelial cells. J Immunol. 159:1997;912-918.
50. Marks R.M., Todd R.F., Ward P.A. Rapid induction of neutrophil-endothelial adhesion by endothelial complement fixation. Nature. 339:1989;314-317.
51. Foreman K.E., Glovsky M.M., Warner R.L., Horvath S.J., Ward P.A. Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells. Inflammation. 20:1996;1-9.
52. Johnson P.A., Alexander H.D., McMillan S.A., Maxwell A.P. Up-regulation of the endothelial cell adhesion molecule intercellular adhesion molecule-1 (ICAM-1) by autoantibodies in autoimmune vasculitis. Clin Exp Immunol. 108:1997;234-242.
53. Johnson P.A., Alexander H.D., McMillan S.A., Maxwell A.P. Up-regulation of the granulocyte adhesion molecule Mac-1 by autoantibodies in autoimmune vasculitis. Clin Exp Immunol. 107:1997;513-519.
54. Sibelius U., Hattar K., Schenkel A., et al. Wegener's granulomatosis anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response . J Exp Med. 187:1998;497-503.
55. Mayet W.J., Csernok E., Szymkowiak C., Gross W.L., Meyer zum Buschenfelde K.H. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood. 82:1993;1221-1229.
56. Mayet A.J., Schwarting A., Orth T., Duchmann R., Meyer zum Buschenfelde K.H. Antibodies to proteinase 3 mediate expression of vascular cell adhesion molecule-1 (VCAM-1). Clin Exp Immunol. 103:1996;259-267.
57. Jenne D.E., Frohlich L., Hummel A.M., Specks U. Cloning and functional expression of the murine homologue of proteinase 3 implications for the design of murine models of vasculitis . FEBS Letters. 408:1997;187-190.
58. Falk R.J., Terrell R.S., Charles L.A. Anti-neutrophil cytoplasmic antoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA. 87:1990;4115.
59. Brooks C.J., King W.J., Radford D.J., Adu D., McGrath M., Savage C.O. IL-1 beta production by human polymorphonuclear leukocytes stimulated by anti-neutrophil cytoplasmic autoantibodies relevance to systemic vasculitis . Clin Exp Immunol. 106:1996;273-279.
60. Kocher M., Siegel M.E., Edberg J.C., Kimberly R.P. Cross-linking of Fcγ receptor IIa and Fcγ receptor IIIb induces different proadhesive phenotypes on human neutrophils. J Immunol. 159:1997;3940-3948.
61. Kocher M., Edberg J.C., Fleit H.B., Kimberly R.P. Antineutrophil cytoplasmic antibodies (ANCA) preferentially engage FcγRIIIb on human neutrophils. J Immunol. 161:1998;6090-6914.
62. Mulder A.H., Heeringa P., Brouwer E., Limburg P.C., Kallenberg C.G. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) a Fc gamma RII-dependent process . Clin Exp Immunol. 98:1994;270-278.
63. Porges A.J., Redecha P.B., Kimberly W.T., Csernok E., Gross W.L., Kimberly R.P. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol. 153:1994;1271-1280.
64. Ewert B.H., Jennette J.C., Falk R.J. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kid Intl. 41:1992;375-383.
65. Ewert B.H., Becker M.E., Jennette J.C., Falk R.J. Antimyeloperoxidase antibodies induce neutrophil adherence to cultured human endothelial cells. Ren Failure. 17:1995;125-133.
66. Chan T.M., Yu P.M., Tsang K.L.C., Cheng I.K.P. Endothelial cell binding by human polyclonal anti-DNA antibodies relationship to disease activity and endothelial functional alterations . Clin Exp Immunol. 100:1995;506-513.
67. Lai K.N., Leung J.C.K., Lai K.B., Wong K.C., Lai C.K.W. Upregulation of adhesion molecule expression on endothelial cells by anti-DNA autoantibodies in systemic lupus erythematosus. Clin Immunol and Immunopathol. 81:1996;229-238.
68. Kalogeris TJ, Kevil CG, Laroux FS, Coe LL, Phifer TJ, Alexander JS. Differential monocyte adhesion and adhesion molecule expression in venous and arterial endothelial cells. Am J Physiol 1999;276:L9-L19.
69. Theofilpoulos A.N., Dixon F.J. Murine models of systemic lupus erythematosus. Adv Immunol. 37:1985;269-391.
70. Nagata S., Goldstein P. The Fas death factor. Science. 267:1995;1449-1456.
71. Alexander E.L., Moyer C.F., Travlos G.S., Roths J.B., Murphy E.D. Two histopathologic types of inflammatory vascular disease in MRL/Mp autoimmune mice. Model for human vasculitis in CTD. Arthr Rheum. 28:1985;1146-1155.
72. Moyer C.F., Strandberg J.D., Reinisch C.L. Systemic mononuclear cell vasculitis in MRL/Mp-lpr/lpr mice. A histologic and immunocytochemical analysis. Am J Pathol. 127:1987;229-242.
73. Berden J.H.M., Hang L., McConahey P.J., Dixon F.J. Analysis of vascular lesions in murine SLE:1. Association with serologic abnormalities. J Immunol. 130:1983;1699-1705.
74. lpr mice from early lethality. J Immunol. 159:1997;2058-2067.
75. Kettritz R., Yang J.J., Kinjoh K., Jennette J.C., Falk R.J. Animal models in ANCA-vasculitis. Clin Exp Immunol. 101:(suppl 1):1995;12-15.
76. 1 mice association with anticardiolipin autoantibodies (43903) . PSEBM. 209:1995;279-285.
77. Connolly M.K., Kitchens E.A., Chan B., Jardieu P., Wofsy D. Treatment of murine lupus with monoclonal antibodies to lymphocyte function-associated antigen-1 dose dependent inhibition of autoantibody production and blockade of the immune response to therapy . Clin Immunol Immunopathol. 72:1994;198-203.
78. Brozna J.P. Shwartzman reaction. Sem Thromb Hem. 16:1990;326-332.
79. Argenbright L.W., Barton R.W. The Shwartzman response a model of ICAM-1 dependent vasculitis . Agents Actions. 34:1991;208-210.
80. Argenbright L.W., Barton R.W. Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo the Shwartzman reaction revisited . J Clin Invest. 89:1992;259-272.
81. Rote W.E., Dempsey E., Maki S., Vlasuk G.P., Moyle M. The role of CD11/CD18 integrins in the reverse passive Arthus reaction in rat dermal tissue. J Leukoc Biol. 59:1996;254-261.
82. Santos L.L., Huang X.R., Berndt M.C., Holdsworth S.R. P-selectin requirement for neutrophil accumulation and injury in the direct passive Arthus reaction. Clin Exp Immunol. 112:1998;281-286.
83. Smith R.J., Chosay J.G., Dunn C.J., Manning A.M., Justen J.M. ICAM-1 mediates leukocyte-endothelium adhesive interactions in the reversed passive Arthus reaction. J Leukoc Biol. 59:1996;333-340.
84. 2 integrins and ICAM-1 in lung injury after deposition of IgG and IgA immune complexes. J Immunol. 150:1993;2407-2417.
85. Tang T., Rosenkranz A., Assmann K.J.M., et al. A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis . J Exp Med. 186:1997;1853-1863.
86. Kavanaugh A.F., Davis L.S., Nichols L.A., et al. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule-1. Arthr Rheum. 37:1994;992.
87. Bullard D.C., Beaudet A.L. Analysis of selectin mutant mice. Vestweber D. The Selectins Initiators of Leukocyte Endothelial Adhesion . 1997;133-142 Harwood Academic Publishers, Amsterdam.
88. Wilson R.W., Ballantyne C.M., Smith C.W., et al. Gene targeting yields a CD18-mutant mouse for study of inflammation. J Immunol. 151:1993;1571-1578.
89. Lu H., Smith C.W., Perrard J., et al. LFA-1 is sufficient in mediating neutrophil transmigration in Mac-1 deficient mice. J Clin Invest. 99:1997;1340-1350.
90. Sligh J.E. Jr, Ballantyne C.M., Rich S.S., et al. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci USA. 90:1993;8529-8533.
91. Moyer C.F., Huggins E., Sarantopoulos S., et al. Cloned endothelium derived from autoimmune vascular disease retain structural and functional characteristics of normal endothelial cells. Exp Cell Res. 199:1992;63-73.
92. Libby P., Ordovas J.M., Birinyi L.K., Auger K.R., Dinarello C.A. Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J Clin Invest. 78:1986;1432-1438.